BCLC 2022 update: Important advances, but missing external beam radiotherapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Large Language Models for Multidisciplinary Tumor Board Decision-Making in Primary Liver Tumors: A Retrospective Single-Center Study.Cancers · 2026
   Article
2. Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma.Clinical and translational radiation oncology · 2024
   Article
3. Role of Flex-Dose Delivery Program in Patients Affected by HCC: Advantages in Management of Tare in Our Experience.Journal of clinical medicine · 2024
   Article
4. Do We Have a Winner? Advocating for SBRT in HCC Management.Clinical and translational radiation oncology · 2024
   Article
5. Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis.Experimental hematology & oncology · 2023
   Article
6. Evaluation of the Clinical Efficacy of Intensity-Modulated Radiotherapy Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Extrahepatic Oligometastasis and Prognostic Factors for Patient Survival.International journal of general medicine · 2023
   Article
7. Current management of liver diseases and the role of multidisciplinary approach.World journal of hepatology · 2022
   Article
8. Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity.JHEP reports : innovation in hepatology · 2022
   Review
9. Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective.Journal of personalized medicine · 2022
   Review
10. 2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations.Journal of clinical and experimental hepatology
    Review

Corrections and comments

• Commented on by
  Reply to: "Correspondence on the <BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update>".2022
• Comment on
  BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.2022

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as